Navigation Links
Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Date:10/2/2007

San Antonio Researcher, Educator Brings Expertise to Organization's Focus

on Breast Cancer Disparities

DALLAS, Oct. 2 /PRNewswire/ -- Susan G. Komen for the Cure, the global leader in the breast cancer movement, has appointed Amelie G. Ramirez, DrPH, of San Antonio, to its Scientific Advisory Board.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070122/NYM084LOGO )

Ramirez joins a group of five other leading breast cancer researchers and clinicians who comprise Komen's Scientific Advisory Board. The group's leader is Dr. Eric P. Winer, internationally known medical oncologist, researcher and educator from the Dana-Farber Cancer Institute and Harvard Medical Center, who is Komen's chief scientific advisor. Komen's Scientific Advisory Board lends insight and guidance to Komen in its grantmaking and health education initiatives. Komen's Scientific Advisory Board members also provide expert perspective and commentary on breaking news and emerging developments in breast cancer research and treatment.

Ramirez, who also serves as chairman of Komen's National Hispanic/Latino Advisory Council, is a professor of epidemiology and biostatistics at the University of Texas Health Science Center at San Antonio (UTHSCSA), where she also is founding director of the Institute for Health Promotion Research. In 2006, Dr. Ramirez received two endowments to support her research and that of the Institute. At UTHSCSA, she was named the Dielmann Chair in Health Disparities Research and Community Outreach. At the Cancer Therapy and Research Center (CTRC) in San Antonio, Dr. Ramirez was given the Max and Minnie Tomerlin Voelcker Endowed Chair in Cancer Healthcare Disparities and Outreach. Dr. Ramirez is director of outreach and health disparities at the CTRC.

Over the past 25 years, she has directed numerous state-, federal- and privately funded research programs focusing on human and organizational communication to reduce chronic disease and cancer health disparities affecting Hispanics/Latinos and other populations. She has authored numerous peer-reviewed articles and is frequently invited to speak at scientific meetings.

Ramirez is a former member of the National Cancer Advisory Board and the National Heart, Lung, and Blood Advisory Council of the National Institutes of Health.

"Dr. Ramirez's unique expertise and keen insight has proven invaluable to Komen identifying and addressing breast health disparities among specific population groups, including Hispanic and Latino people. As a member of its Scientific Advisory Board (SAB), Dr. Ramirez will be instrumental in Komen's ability to reach even more deeply into areas of our society that remain medically underserved," said Dr. Winer.

In addition to Dr. Winer and Dr. Ramirez, the SAB includes the following physicians and researchers:

-- Melissa L. Bondy, Ph.D., professor of epidemiology at the University of

Texas M.D. Anderson Cancer Center, Houston, and director of the

Childhood Cancer Epidemiology and Prevention Center, a collaborative

program between M.D. Anderson Cancer Center, Baylor College of Medicine

and Texas Children's Hospital.

-- Powel Brown, professor of medicine, Baylor College of Medicine;

associate director of cancer prevention and director of cancer

prevention and populations studies program, Dan L. Duncan Cancer

Center; and associate director of research at the Breast Care Center

Baylor-Methodist.

-- H. Kim Lyerly, M.D., George Barth Geller Professor of Research at Duke

University, Durham, N.C.; director of the Duke Comprehensive Cancer

Center and principal investigator of the Duke Specialized Program in

Research Excellence (SPORE).

-- George W. Sledge, M.D., Ballve-Lantero Professor of Oncology and

co-director of the breast cancer program at the Indiana University

Cancer Center. He is also professor of medicine and pathology at

Indiana University School of Medicine. Dr. Sledge was awarded the Komen

Brinker Award of Scientific Distinction in 2006.

-- Sara Sukumar, Ph.D., professor of oncology and pathology and co-

director of the breast cancer research program at the Sidney Kimmel

Cancer Center at Johns Hopkins University School of Medicine in

Baltimore.

About Susan G. Komen for the Cure

Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world's largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure, we have invested nearly $1 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit http://www.komen.org or call 1-800 I'M AWARE.


'/>"/>
SOURCE Susan G. Komen for the Cure
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Scientific markers of aging described
2. A Settlement Over Stem Cell Controversy Through Scientific Research
3. A Scientific Explanation For Out Of Body Experience
4. PUFA Good For Heart: Gets The Scientific Seal
5. Forensic Phonetics – Scientific Solution for Legal Problem
6. Old Indian Advice Has A Scientific Backing Now!
7. India To Highlight Its Scientific Achievements
8. Thumbs up in weight loss for vegetarian diets: scientific review
9. Scientific Research in a War Zone
10. Unscientific Depression Drugs aplenty in Health Stores
11. No Scientific Evidence to Support Drug Safety Recommendations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... U.S. Surgeon General, Dr. Vivek ... Dr. Murthy explains how he was inspired to practice medicine at an early age ... is about more than making diagnoses and prescribing medicine,” he states. “It is about ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, ... ... today, featuring an inspirational interview of two ostomy patients, standing as living proof ... million people suffer from digestive diseases and issues that spike around the holidays. ...
(Date:12/2/2016)... York, NY (PRWEB) , ... December 02, 2016 , ... ... high school and while 84 percent of parents report speaking with their child about ... pornography and sexually transmitted diseases. , Mediaplanet is proud to announce the launch of ...
(Date:12/2/2016)... ... December 02, 2016 , ... CloudLIMS.com, ... its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and testing ... shipping and disposal. The new version is a faster and a more efficient ...
(Date:12/2/2016)... ... December 02, 2016 , ... Universal Medical Systems, Inc. ... the first company to offer robotic imaging to veterinary medicine is sponsoring the ... 941 for the American Association of Equine Practitioners 62nd Annual Convention from December ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... at 5,251.11, down 1.36%; the Dow Jones Industrial Average edged ... closed at 2,191.08, down 0.35%. Losses were broad based as ... Today, Stock-Callers.com has initiated research reports on the following Services ... N.V. (NASDAQ: QGEN ), INC Research Holdings Inc. ...
(Date:12/2/2016)... Conn. , Dec. 1, 2016  Today, Simpson ... announced the honor of being selected as winners of ... Simpson Healthcare Executives Website at the PLATINUM level, Blue ... Training Module at the GOLD Level, and our proprietary ... At Simpson Healthcare Executives, we are excited to ...
(Date:12/2/2016)... -- bioLytical Laboratories (das "Unternehmen"), ein Weltführer bei schnellen Tests ...  in einer Version mit geringeren Kosten einzuführen.  ... ... New: INSTI Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444833 ) Der ...
Breaking Medicine Technology: